LEADER 05284nam 2200685Ia 450 001 9910807006703321 005 20200520144314.0 010 $a0-429-14580-2 010 $a1-4200-4436-2 024 7 $a10.3109/9781420044362 035 $a(CKB)2440000000014927 035 $a(EBL)1398233 035 $a(Au-PeEL)EBL1398233 035 $a(CaPaEBR)ebr10231547 035 $a(CaONFJC)MIL741358 035 $a(OCoLC)905983838 035 $a(OCoLC)892787778 035 $a(MiAaPQ)EBC1398233 035 $a(OCoLC)1289517935 035 $a(FINmELB)ELB152021 035 $a(EXLCZ)992440000000014927 100 $a20071115d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aModified-release drug delivery technology$hVolume 1 /$fedited by Michael J. Rathbone ... [et al.] 205 $a2nd ed. 210 $aNew York $cInforma Healthcare$dc2008 215 $a1 online resource (514 p.) 225 1 $aDrugs and the pharmaceutical sciences ;$v183 300 $aDescription based upon print version of record. 311 $a1-336-10072-9 311 $a1-4200-4435-4 320 $aIncludes bibliographical references and indexes. 327 $aFront Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum 327 $aChapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) 327 $aChapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract 327 $aChapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology 327 $aChapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover 330 $aThis two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes, found in areas like:Oral Ocular Dermal and transdermal VaginalColonic Oral mucosal Nasal PulmonaryProviding insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value, topics include:Intellectual property rights and regulatory issues and challengesosmotic systems and Qtrol. Qdis. Matrix Systemsthiolated polymers for CR, Oradur. IDD technology, and chronotherapy technologyOral-lynTM 410 0$aDrugs and the pharmaceutical sciences ;$v183. 606 $aControlled release technology 606 $aControlled release preparations 606 $aDrug delivery systems 606 $aPharmaceutical technology 615 0$aControlled release technology. 615 0$aControlled release preparations. 615 0$aDrug delivery systems. 615 0$aPharmaceutical technology. 676 $a615.19 701 $aRathbone$b Michael J.$f1957-$0318416 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910807006703321 996 $aModified-release drug delivery technology$94125831 997 $aUNINA